A Study of MK0594 in Patients With Alcohol Dependence (0594-020)
Phase 2
Terminated
- Conditions
- Alcohol Dependence
- First Posted Date
- 2009-02-04
- Last Posted Date
- 2021-05-20
- Lead Sponsor
- Vyne Therapeutics Inc.
- Target Recruit Count
- 162
- Registration Number
- NCT00835718
Safety and Efficacy of MK0594 to Treat Overactive Bladder (0594-003)
Phase 2
Completed
- Conditions
- Urinary IncontinenceOveractive Bladder
- First Posted Date
- 2006-02-13
- Last Posted Date
- 2021-05-19
- Lead Sponsor
- Vyne Therapeutics Inc.
- Target Recruit Count
- 557
- Registration Number
- NCT00290563
© Copyright 2025. All Rights Reserved by MedPath